Arich Enterprise Co., Ltd. (TPEX:4173)
Taiwan · Delayed Price · Currency is TWD 21.10
+0.05 (0.24%)
Dec 31, 2025, 2:31 PM CST
Arich Enterprise Market Cap
Arich Enterprise has a market cap or net worth of 1.57 billion as of December 31, 2025.
Market Cap
1.57B
Enterprise Value
1.22B
Revenue
1.48B
Ranking
n/a
PE Ratio
15.78
Stock Price
21.10
Market Cap Chart
Since July 10, 2012, Arich Enterprise's market cap has increased from 863.24M to 1.57B, an increase of 82.28%. That is a compound annual growth rate of 4.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 1.57B | -4.09% |
| Dec 31, 2024 | 1.64B | 0.23% |
| Dec 29, 2023 | 1.64B | 13.44% |
| Dec 30, 2022 | 1.44B | 7.50% |
| Dec 30, 2021 | 1.34B | -28.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 240.39B |
| PharmaEssentia | 173.83B |
| Lotus Pharmaceutical | 74.42B |
| Heron Neutron Medical | 70.65B |
| Bora Pharmaceuticals Co., LTD. | 60.52B |
| Lin BioScience | 32.84B |
| Lumosa Therapeutics | 32.77B |
| Center Laboratories | 31.06B |